Mashhad University of Medical Sciences is a medical school in Iran. Located in Razavi Khorasan province in the city of Mashhad, it was established in 1949 with Ferdowsi University of Mashad and separated in 1986 from its parent institution by national legislation.

During the past decade, Mashad University of Medical Sciences conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mashad University of Medical Sciences" are "Graves Disease" (1 trials), "Hyperprolactinoma" (1 trials), "Malignant Neoplasm of Thyroid Stage I" (1 trials) and "Malignant Neoplasm of Thyroid Stage II" (1 trials). Many other conditions were trialed in "Mashad University of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Mashad University of Medical Sciences" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Curcumin" (1 trials), "Metformin" (1 trials) and "Methimazole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mashad University of Medical Sciences" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mashad University of Medical Sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mashad University of Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mashad University of Medical Sciences, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".